Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 3Phase 3 1Phase 1 1

Status

Completed 4Withdrawn 1Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 9INDUSTRY 8

Study Type

Interventional 8

Sponsor

Cancer Type

Dermatologic 4Tumor-Agnostic 1Gynecologic 1

Conditions

Keratosis, Actinic 4Uterine Cervical Dysplasia 1Pilonidal Sinus 1Keratosis 1Condylomata Acuminata 1Carcinoma 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
INDUSTRY × Ointments × Clear all
NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting
280 enrolled
Dermatologic

Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting
447 enrolled
Dermatologic

Keratosis, Actinic

NCT04273997 2021-09-22

Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds

S.L.A. Pharma AG

Phase 2 Unknown
80 enrolled

Pilonidal Sinus

NCT03083470 2019-05-15

Study of SOR007 Ointment for Actinic Keratosis

DFB Soria, LLC

Phase 2 Completed
33 enrolled 15 charts
Dermatologic

Keratosis, Actinic

NCT03143491 2017-10-18

Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)

DFB Soria, LLC

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Dysplasia

NCT02587819 2016-04-14

Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment

Biosceptre

Phase 1 Completed
21 enrolled 9 charts
Tumor-Agnostic

Carcinoma

NCT01082302 2010-09-08

Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage

MediGene

Phase 4 Completed
43 enrolled

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡